Follistatin-344 vs Semaglutide
Updated July 27, 2026 · Reviewed by the PeptidesDB Editorial team
A data-driven comparison of Follistatin-344 and Semaglutide (also searched as Semaglutide vs Follistatin-344) — effect profiles, evidence, side effects, and which suits weight loss, muscle, or healing goals.
Verdict
Follistatin-344 centers on muscle, while Semaglutide leans toward metabolic. On indexed research, Semaglutide is ahead (Follistatin-344: 5 studies, Human evidence; Semaglutide: 7, Human clinical). Choose by goal — and read the primary studies. This is research information, not medical advice.
Key takeaways
- •Follistatin-344 is strongest for muscle; Semaglutide for metabolic.
- •Evidence: Follistatin-344 Human evidence (5 studies) vs Semaglutide Human clinical (7).
- •Check the FDA-approval status chips above before assuming a legal use pathway.
Effect profiles, overlaid
At a glance
Myostatin inhibition | Muscle growth
GLP-1 Receptor Agonist | Weight Loss & Diabetes
Follistatin-344 vs Semaglutide: side-by-side
| Metric | Follistatin-344 | Semaglutide |
|---|---|---|
| Class | Muscle | Weight Loss |
| Regulatory status | Research use only | FDA-approved |
| Evidence grade | Human evidence | Human clinical |
| Studies indexed | 5 | 7 |
| Research level | Limited Research | FDA Approved |
| Strongest effect | Muscle & body comp | Metabolic & appetite |
| Healing & recovery | 1.0▲ | 0.0 |
| Muscle & body comp | 5.0▲ | 0.0 |
| Metabolic & appetite | 2.0 | 5.0▲ |
| Neuro & mood | 1.0▲ | 0.0 |
| Sleep & circadian | 0.0 | 0.0 |
| Inflammation & immune | 1.0▲ | 1.0▲ |
| Skin & aesthetics | 2.0 | 4.0▲ |
▲ marks the higher AI-assigned effect score (0–5, describing where the literature concentrates — not clinical efficacy).
Mechanism & pharmacokinetics
| Property | Follistatin-344 | Semaglutide |
|---|---|---|
| Mechanism | Myostatin inhibitor | GLP-1 receptor agonist |
| Route | — | Subcutaneous injection (oral form also available) |
| Half-life | — | ~7 days (≈165 h) |
| Time to peak | — | 1–3 days |
| Duration of action | — | Weekly dosing |
Established pharmacology — curated for well-characterized compounds and AI-summarized otherwise. A blank (—) means no reliable single value is published (half-life figures for some peptides genuinely disagree across sources). Verify against primary sources such as FDA labels and ClinicalTrials.gov.
What is Follistatin-344?
### Follistatin-344 Summary Follistatin-344 is a glycoprotein that plays a crucial role in the regulation of muscle growth and development by inhibiting myostatin, a negative regulator of muscle mass. Its potential therapeutic applications are being explored in various fields, including muscle wasting disorders and regenerative medicine.
Full Follistatin-344 profile, mechanism & studies →What is Semaglutide?
### Semaglutide Summary Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that has been investigated for its role in managing type 2 diabetes and obesity. Its efficacy in promoting weight loss and improving glycemic control has garnered significant attention in recent clinical research.
Full Semaglutide profile, mechanism & studies →Which is better for your goal?
| Goal | Better fit | Why |
|---|---|---|
| Healing | Follistatin-344 | 1.0/5 effect signal |
| Muscle | Follistatin-344 | 5.0/5 effect signal |
| Metabolic | Semaglutide | 5.0/5 effect signal |
| Neuro | Follistatin-344 | 1.0/5 effect signal |
| Inflammation | Even | Both ~1.0/5 |
| Skin | Semaglutide | 4.0/5 effect signal |
Fit reflects community-perceived effect profiles — not head-to-head trials. Read each peptide's studies before deciding.
Can you stack Follistatin-344 and Semaglutide?
People sometimes combine peptides that target different pathways, but there is little controlled research on this specific pairing and the interactions aren't well characterized. Because at least one is a research-use compound, we don't publish stacking or dosing protocols here. Any combination should be discussed with a qualified clinician.
Follistatin-344 vs Semaglutide: side effects
No community-reported effects logged yet.
No community-reported effects logged yet.
Anonymous community reports (count = number of reports), not clinical incidence rates.
What the research says
Follistatin-344 has 5 approved studies indexed (Human evidence), and Semaglutide has 7 (Human clinical). The Librarian re-checks PubMed, Europe PMC and ClinicalTrials daily, so these counts move. Open each profile to read the summaries and sources.
Frequently asked questions
Is Follistatin-344 or Semaglutide better?
It depends on your goal. Follistatin-344 is strongest for muscle; Semaglutide for metabolic. Semaglutide has more indexed studies (7). See the goal-by-goal breakdown above.
Is Follistatin-344 or Semaglutide better for weight loss?
Semaglutide shows the stronger metabolic & appetite profile (5.0/5) in the AI-assigned effect profile — though weight-loss outcomes depend on the individual and the evidence base.
Is Follistatin-344 or Semaglutide better for muscle?
Follistatin-344 leads on the muscle & body-composition axis (5.0/5).
Which has more research, Follistatin-344 or Semaglutide?
Follistatin-344 has 5 approved studies indexed (Human evidence); Semaglutide has 7 (Human clinical). Higher counts mean more to read, not proven superiority.
Can you stack Follistatin-344 and Semaglutide?
Some users combine peptides, but there's little controlled data on this specific pairing, and interactions aren't well characterized. We don't publish stacking protocols for compounds that aren't FDA-approved. Discuss any combination with a qualified clinician.
What are the side effects of Follistatin-344 vs Semaglutide?
Follistatin-344: no community-reported effects logged yet. Semaglutide: none logged yet. These are anonymous reports, not incidence rates — see each profile.
Is Follistatin-344 or Semaglutide FDA-approved?
Follistatin-344 is a research-use compound and is not FDA-approved. Semaglutide is FDA-approved. Research-use status is not a legal clearance to compound or use in humans.
Is Semaglutide better than Follistatin-344?
For metabolic, Semaglutide has the edge; for muscle, Follistatin-344 does. Neither is universally "better" — it's goal-dependent, and both should be weighed against their evidence base above.
Comparing related peptides
Regulatory & legal status
Approval status varies (see the chips at the top). FDA approval and compounding rules for peptides change frequently, and research-use status is not a legal clearance for human use. The FDA does not review compounded drugs for safety, effectiveness, or quality. Verify current status with primary sources before acting. Last reviewed July 27, 2026.